Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 6/2007

01-06-2007 | Erratum

Levels of soluble E-selectin in patients with active Behçet’s disease

Authors: Refik Ali Sari, Ahmet Kiziltunç, Seyithan Taysi, Serpil Akdemir, Mehmet Gündoğdu

Published in: Clinical Rheumatology | Issue 6/2007

Login to get access

Excerpt

Clin Rheumatol (2005) 24:55–59 …
Metadata
Title
Levels of soluble E-selectin in patients with active Behçet’s disease
Authors
Refik Ali Sari
Ahmet Kiziltunç
Seyithan Taysi
Serpil Akdemir
Mehmet Gündoğdu
Publication date
01-06-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 6/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0518-5

Other articles of this Issue 6/2007

Clinical Rheumatology 6/2007 Go to the issue

Case Report

The occurrence of systemic lupus erythematosus in an asymptomatic carrier of human T-cell lymphotropic virus type I

Case Report

Catastrophic antiphospholipid syndrome related to severe ovarian hyperstimulation

Case Report

Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease

Case Report

Catastrophic antiphospholipid syndrome in a 7-year-old girl

Original Article

Tumor necrosis factor-alpha gene promoter polymorphism in patients with familial Mediterranean fever

Case Report

Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits